Cancer Research  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 14, 625-628, October 1, 1954]
© 1954 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nygaard, O.
Right arrow Articles by Nakken, K. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nygaard, O.
Right arrow Articles by Nakken, K. F.

Studies on the Metabolism of Thioacetamide-S35 in the Intact Rat*

Oddvar Nygaard, Lorentz Eldjarn and Karl Ford Nakken

( Norsk Hydro's Institute for Cancer Research, Norwegian Radium Hospital, Oslo, Norway)

1. A method for the labeling of thioacetamide (TAA) with radioactive sulfur has been described.
2. When TAA-S35 was injected subcutaneously into rats, more than 80 per cent of the radioactivity was excreted in the urine during the first 24 hours. Approximately 25 per cent was recovered as unaltered TAA, while most of the remainder was accounted for as free and esterified sulfate.
3. Following injection of TAA-S35 the bone marrow, thyroid, and the adrenals of the rat concentrated the compound temporarily to a considerable degree. However, no tissue showed any exceptionally great retention of radioactive sulfur after repeated injections of TAA-S35.
4. The liver, although it is the only organ showing morphological changes after treatment with TAA, did not concentrate TAA-S35 nor retain S35 to any greater extent than the other tissues.

* This project was supported in part by a grant from Landsforeningen mot Kreft, Oslo, Norway.

Received 4/ 1/54.


This article has been cited by other articles:


Home page
Hum Exp ToxicolHome page
M. T. D. Bueno and B. Spira
Thioacetamide differentially affects the expression and activity of glutathione-S-transferase in the liver of Wistar rats
Human and Experimental Toxicology, September 1, 2004; 23(9): 431 - 437.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1954 by the American Association for Cancer Research.